Tapewire

NYSE · USD

SHW

SHERWIN WILLIAMS CO

Export transactions ↓
Tapewire entity
2948
SEC CIK
0000089800
Parsed reports
715

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2020 Filed Feb 20, 2020 22:40 UTC
IPPOLITO PETER J.President, The Americas Group
Tax withholdingCommon Stock 644 $580.04 $373,545.76
Disclosure

SEC source: 0001209191-20-011226 · doc4.xml · nonDerivative · entry 2

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,332

F2 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of performance-based restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 22:40 UTC
IPPOLITO PETER J.President, The Americas Group
GrantCommon Stock 1,976 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-011226 · doc4.xml · nonDerivative · entry 1

IPPOLITO PETER J. · CIK 0001729232 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,976

F1 · kind: Represents the vesting of performance-based restricted stock units previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2017-2019 performance period.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 22:36 UTC
GARCEAU MARY LSVP, Gen. Counsel & Secretary
Tax withholdingCommon Stock 234 $580.04 $135,729.36
Disclosure

SEC source: 0001209191-20-011223 · doc4.xml · nonDerivative · entry 2

GARCEAU MARY L · CIK 0001368800 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,569

F2 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of performance-based restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 22:36 UTC
GARCEAU MARY LSVP, Gen. Counsel & Secretary
GrantCommon Stock 752 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-011223 · doc4.xml · nonDerivative · entry 1

GARCEAU MARY L · CIK 0001368800 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,803

F1 · kind: Represents the vesting of performance-based restricted stock units previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2017-2019 performance period.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 22:34 UTC
CRONIN JANE M.SVP - Corporate Controller
Tax withholdingCommon Stock 409 $580.04 $237,236.36
Disclosure

SEC source: 0001209191-20-011221 · doc4.xml · nonDerivative · entry 2

CRONIN JANE M. · CIK 0001688222 · SVP - Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,823

F2 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of performance-based restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 22:34 UTC
CRONIN JANE M.SVP - Corporate Controller
GrantCommon Stock 1,317 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-011221 · doc4.xml · nonDerivative · entry 1

CRONIN JANE M. · CIK 0001688222 · SVP - Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,232

F1 · kind: Represents the vesting of performance-based restricted stock units previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2017-2019 performance period.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 22:32 UTC
Baxter Joel D.Pres. & GM, Glob. Supply Chain
Tax withholdingCommon Stock 1,141 $580.04 $661,825.64
Disclosure

SEC source: 0001209191-20-011217 · doc4.xml · nonDerivative · entry 2

Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,435

F2 · kind: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of performance-based restricted stock units.

F3 · balance_after: Of shares listed, 1,277 are restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 22:32 UTC
Baxter Joel D.Pres. & GM, Glob. Supply Chain
GrantCommon Stock 3,073 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-011217 · doc4.xml · nonDerivative · entry 1

Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,576

F1 · kind: Represents the vesting of performance-based restricted stock units previously granted to the reporting person under The Sherwin-Williams Company 2006 Equity and Performance Incentive Plan for the 2017-2019 performance period.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 16:05 UTC GrantCommon Stock 277 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-010932 · doc4.xml · nonDerivative · entry 1

THAMAN MICHAEL H · CIK 0001228309 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,513

F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: Of shares listed, 824 are restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 16:07 UTC GrantCommon Stock 277 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-010933 · doc4.xml · nonDerivative · entry 1

Thornton Matthew III · CIK 0001611473 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,094

F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: Of shares listed, 669 are restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 16:01 UTC GrantCommon Stock 277 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-010930 · doc4.xml · nonDerivative · entry 1

KROPF SUSAN J · CIK 0001051402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,816

F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: Of shares listed, 669 are restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 15:58 UTC GrantCommon Stock 277 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-010929 · doc4.xml · nonDerivative · entry 1

KRAMER RICHARD J · CIK 0001201067 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,581

F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: Of shares listed, 669 are restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 15:56 UTC GrantCommon Stock 277 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-010928 · doc4.xml · nonDerivative · entry 1

Hodnik David F · CIK 0001333169 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,623

F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: Of the shares listed, 669 are restricted stock units.

Read SEC document
February 18, 2020 Filed Feb 20, 2020 15:51 UTC GrantCommon Stock 277 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-010927 · doc4.xml · nonDerivative · entry 1

FETTIG JEFF M · CIK 0001224295 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,149

F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: Of shares listed, 649 are restricted stock units.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:54 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 14,733 $0.00 Strike: $239.55 $0.00
Disclosure

SEC source: 0001209191-20-008671 · doc4.xml · derivative · entry 8

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,733 shares

Expires 2025-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:54 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 400 $574.60 $229,840.00
Disclosure

SEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 6

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,386

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.45 to $574.85 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:54 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 1,639 $573.62 $940,163.18
Disclosure

SEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 5

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,786

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.23 to $574.21 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:54 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 5,512 $572.71 $3,156,777.52
Disclosure

SEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 4

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,425

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.23 to $573.21 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:54 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 5,839 $571.77 $3,338,565.03
Disclosure

SEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 3

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,937

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.25 to $572.19 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:54 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 1,343 $570.87 $766,678.41
Disclosure

SEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 2

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,776

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.23 to $571.21 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:54 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionCommon Stock 14,733 $239.55 $3,529,290.15
Disclosure

SEC source: 0001209191-20-008671 · doc4.xml · nonDerivative · entry 1

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

Read SEC document
February 03, 2020 Filed Feb 4, 2020 22:30 UTC GiftCommon Stock 2,400 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-006462 · doc4.xml · nonDerivative · entry 1

Anton Arthur F · CIK 0001358902 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,284

F1 · balance_after: Of shares listed, 828 are restricted stock units.

Read SEC document
January 24, 2020 Filed Jan 28, 2020 14:17 UTC
Jaye James RSVP - IR & Corp. Comm.
GrantPhantom Stock Units · Derivative 0.34 $594.84 $202.25
Disclosure

SEC source: 0001209191-20-005077 · doc4.xml · derivative · entry 1

Jaye James R · CIK 0001777298 · SVP - IR & Corp. Comm.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0.7

Underlying: Common Stock · 0.34 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the number of phantom stock units that were acquired by the reporting person (in an exempt transaction) under The Sherwin-Williams Company 2005 Key Management Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of common stock and is payable in cash. The phantom stock units have dividend equivalent rights.

F2 · derivative.exercise_date: The phantom stock units become payable generally upon the reporting person's retirement or other termination of service.

F2 · derivative.expiration_date: The phantom stock units become payable generally upon the reporting person's retirement or other termination of service.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 20:16 UTC
Jaye James RSVP - IR & Corp. Comm.
GrantPhantom Stock Units · Derivative 0.36 $567.09 $204.15
Disclosure

SEC source: 0001209191-20-003274 · doc4.xml · derivative · entry 1

Jaye James R · CIK 0001777298 · SVP - IR & Corp. Comm.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0.36

Underlying: Common Stock · 0.36 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the number of phantom stock units that were acquired by the reporting person (in an exempt transaction) under The Sherwin-Williams Company 2005 Key Management Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of common stock and is payable in cash. The phantom stock units have dividend equivalent rights.

F2 · derivative.exercise_date: The phantom stock units become payable generally upon the reporting person's retirement or other termination of service.

F2 · derivative.expiration_date: The phantom stock units become payable generally upon the reporting person's retirement or other termination of service.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 21:17 UTC GrantPhantom Stock Units · Derivative 65.15 $567.91 $36,999.34
Disclosure

SEC source: 0001209191-20-002252 · doc4.xml · derivative · entry 1

KROPF SUSAN J · CIK 0001051402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,906.01

Underlying: Common Stock · 65.15 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable in cash generally upon the reporting person's retirement.

F1 · shares: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable in cash generally upon the reporting person's retirement.

F1 · derivative.exercise_date: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable in cash generally upon the reporting person's retirement.

F1 · derivative.expiration_date: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable in cash generally upon the reporting person's retirement.

F2 · balance_after: Includes phantom stock units acquired pursuant to the dividend reinvestment feature of the plan.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 21:14 UTC GrantCommon Stock 70.43 $567.91 $39,997.90
Disclosure

SEC source: 0001209191-20-002249 · doc4.xml · nonDerivative · entry 1

WUNNING STEVEN H · CIK 0001171788 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 1,805.51

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 21:11 UTC GrantCommon Stock 55.03 $567.91 $31,252.09
Disclosure

SEC source: 0001209191-20-002243 · doc4.xml · nonDerivative · entry 1

THAMAN MICHAEL H · CIK 0001228309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 772.92

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 20:56 UTC GrantCommon Stock 15.96 $567.91 $9,063.84
Disclosure

SEC source: 0001209191-20-002237 · doc4.xml · nonDerivative · entry 1

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 608.14

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 20:53 UTC GrantCommon Stock 55.03 $567.91 $31,252.09
Disclosure

SEC source: 0001209191-20-002235 · doc4.xml · nonDerivative · entry 1

KRAMER RICHARD J · CIK 0001201067 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 2,929.22

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 20:50 UTC GrantCommon Stock 13.76 $567.91 $7,814.44
Disclosure

SEC source: 0001209191-20-002232 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 44.93

F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement.

F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:45 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 14,734 $0.00 Strike: $239.55 $0.00
Disclosure

SEC source: 0001209191-19-060439 · doc4.xml · derivative · entry 9

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,734 shares

Expires 2025-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:45 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 300 $580.22 $174,066.00
Disclosure

SEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 7

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,386

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $580.04 to $580.51 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:45 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 516 $579.50 $299,022.00
Disclosure

SEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 6

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,686

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.04 to $580.01 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:45 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 631 $578.59 $365,090.29
Disclosure

SEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 5

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,202

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.00 to $578.69 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:45 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 4,820 $577.40 $2,783,068.00
Disclosure

SEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 4

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,833

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.96 to $577.95 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:45 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 6,415 $576.49 $3,698,183.35
Disclosure

SEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 3

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,653

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.96 to $576.94 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:45 UTC
MORIKIS JOHN GDirector · Chairman and CEO
SaleCommon Stock 2,052 $575.52 $1,180,967.04
Disclosure

SEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 2

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,068

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.95 to $575.92 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 12, 2019 Filed Dec 13, 2019 21:45 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionCommon Stock 14,734 $239.55 $3,529,529.70
Disclosure

SEC source: 0001209191-19-060439 · doc4.xml · nonDerivative · entry 1

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,120

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.

Read SEC document
December 04, 2019 Filed Jan 7, 2020 19:33 UTC
Sewell David BPresident and COO
GiftCommon Stock 174 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-002202 · doc5.xml · nonDerivative · entry 1

Sewell David B · CIK 0001617514 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,721

Read SEC document
November 11, 2019 Filed Nov 13, 2019 14:46 UTC
ERTER AARON MPresident, Perf Coatings Grp
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,380 $0.00 Strike: $383.92 $0.00
Disclosure

SEC source: 0001209191-19-056259 · doc4.xml · derivative · entry 5

ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 520

Underlying: Common Stock · 1,380 shares

Expires 2027-10-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2019 Filed Nov 13, 2019 14:46 UTC
ERTER AARON MPresident, Perf Coatings Grp
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,900 $0.00 Strike: $383.92 $0.00
Disclosure

SEC source: 0001209191-19-056259 · doc4.xml · derivative · entry 4

ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,900 shares

Expires 2027-10-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2019 Filed Nov 13, 2019 14:46 UTC
ERTER AARON MPresident, Perf Coatings Grp
SaleCommon Stock 3,280 $580.62 $1,904,433.60
Disclosure

SEC source: 0001209191-19-056259 · doc4.xml · nonDerivative · entry 2

ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,506

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $580.53 to $580.71 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Of shares listed, 1,597 are restricted stock units.

Read SEC document
November 11, 2019 Filed Nov 13, 2019 14:46 UTC
ERTER AARON MPresident, Perf Coatings Grp
Exercise / conversionCommon Stock 3,280 $383.92 $1,259,257.60
Disclosure

SEC source: 0001209191-19-056259 · doc4.xml · nonDerivative · entry 1

ERTER AARON M · CIK 0001713958 · President, Perf Coatings Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,786

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 30, 2019 Filed Nov 1, 2019 14:23 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 370 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-19-054682 · doc4.xml · derivative · entry 3

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,263

Underlying: Common Stock · 370 shares

Expires 2026-10-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 30, 2019 Filed Nov 1, 2019 14:23 UTC
MORIKIS JOHN GDirector · Chairman and CEO
Exercise / conversionCommon Stock 370 $270.12 $99,944.40
Disclosure

SEC source: 0001209191-19-054682 · doc4.xml · nonDerivative · entry 1

MORIKIS JOHN G · CIK 0001203523 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2019 Filed Oct 29, 2019 17:10 UTC
Baxter Joel D.Pres. & GM, Glob. Supply Chain
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 370 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-19-054307 · doc4.xml · derivative · entry 3

Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,030

Underlying: Common Stock · 370 shares

Expires 2026-10-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2019 Filed Oct 29, 2019 17:10 UTC
Baxter Joel D.Pres. & GM, Glob. Supply Chain
Exercise / conversionCommon Stock 370 $270.12 $99,944.40
Disclosure

SEC source: 0001209191-19-054307 · doc4.xml · nonDerivative · entry 1

Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Of shares listed, 1,277 are restricted stock units.

Read SEC document
October 24, 2019 Filed Oct 28, 2019 15:01 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,417 $0.00 Strike: $78.26 $0.00
Disclosure

SEC source: 0001209191-19-054206 · doc4.xml · derivative · entry 6

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,417 shares

Expires 2021-10-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 24, 2019 Filed Oct 28, 2019 15:01 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,416 $0.00 Strike: $78.26 $0.00
Disclosure

SEC source: 0001209191-19-054206 · doc4.xml · derivative · entry 5

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,416 shares

Expires 2021-10-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 24, 2019 Filed Oct 28, 2019 15:01 UTC
GILLIGAN THOMAS PSVP-Human Resources
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,417 $0.00 Strike: $78.26 $0.00
Disclosure

SEC source: 0001209191-19-054206 · doc4.xml · derivative · entry 4

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,417 shares

Expires 2021-10-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.